Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-116821
Filing Date
2024-11-12
Accepted
2024-11-12 16:26:06
Documents
3
Period of Report
2024-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2427734d2_6k.htm 6-K 10459
2 EXHIBIT 99.1 tm2427734d2_ex99-1.htm EX-99.1 69297
3 GRAPHIC tm2427734d2_ex99-1img001.jpg GRAPHIC 11733
  Complete submission text file 0001104659-24-116821.txt   97228
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 241448721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)